BTIG analyst Gregory Lewis has reiterated a Buy rating on Core Scientific (NASDAQ: CORZ), maintaining a price target of $38. This reaffirmation signals continued institutional confidence in the mining and data center operator’s equity prospects. The decision to hold the existing target suggests that recent market movements or operational developments have not altered the firm’s fundamental valuation thesis for the stock.

Analyst Recommendation Details

The research note from BTIG confirms no changes to the current stance on Core Scientific. Investors relying on this coverage will see consistent guidance as the analyst retains both the positive recommendation and the specific valuation ceiling.

Market Implications

The maintenance of the $38 price target provides a clear reference point for traders monitoring Core Scientific. By not lowering the target, BTIG implies that the current market price remains below its intrinsic value estimate, supporting the Buy classification. This stability in analyst opinion can reduce volatility concerns for holders who track institutional sentiment closely.

What the Numbers Show

The consistency of the $38 target alongside the reiterated Buy rating indicates a steady view of Core Scientific’s risk-reward profile. Without a revision to the price target, the analyst is likely viewing recent performance as aligned with prior expectations. This lack of adjustment serves as a neutral-to-positive signal, confirming that no negative surprises have emerged to warrant a downgrade or target cut.

BTIG analyst Gregory Lewis has maintained a Buy rating on Core Scientific (NASDAQ: CORZ) and increased the price target to $38 from $33. The revised target reflects a more optimistic outlook on the company's valuation potential.

Analyst Rating and Price Target

The rating upgrade comes as BTIG adjusts its expectations for Core Scientific's performance. The new price target of $38 represents an increase over the previous $33 target.

Core Scientific trades on the NASDAQ under the ticker symbol CORZ.